See more : Enel Américas S.A. (ENELAM.SN) Income Statement Analysis – Financial Results
Complete financial analysis of Green Cross Holdings Corporation (005257.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Green Cross Holdings Corporation, a leading company in the Biotechnology industry within the Healthcare sector.
- EVmo, Inc. (YAYO) Income Statement Analysis – Financial Results
- MiNK Therapeutics, Inc. (INKT) Income Statement Analysis – Financial Results
- Alternate Health Corp. (AHGIF) Income Statement Analysis – Financial Results
- Wake Up Now, Inc. (WORC) Income Statement Analysis – Financial Results
- Provision Information Co.,Ltd. (6590.TWO) Income Statement Analysis – Financial Results
Green Cross Holdings Corporation (005257.KS)
About Green Cross Holdings Corporation
Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was founded in 1967 and is headquartered in Yongin, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,626.64B | 1,711.31B | 1,537.83B | 1,504.12B | 1,369.71B | 1,334.88B | 1,287.92B | 1,197.90B | 1,047.81B | 975.33B | 888.17B | 811.77B | 767.91B | 791.02B | 643.21B | 516.10B | 442.30B |
| Cost of Revenue | 1,142.01B | 1,129.51B | 1,017.23B | 1,063.49B | 997.39B | 989.01B | 921.11B | 845.83B | 708.82B | 664.83B | 613.27B | 558.19B | 509.06B | 476.32B | 373.46B | 311.85B | 261.89B |
| Gross Profit | 484.63B | 581.80B | 520.59B | 440.63B | 372.32B | 345.87B | 366.80B | 352.08B | 339.00B | 310.50B | 274.89B | 253.58B | 258.86B | 314.69B | 269.75B | 204.24B | 180.40B |
| Gross Profit Ratio | 29.79% | 34.00% | 33.85% | 29.29% | 27.18% | 25.91% | 28.48% | 29.39% | 32.35% | 31.84% | 30.95% | 31.24% | 33.71% | 39.78% | 41.94% | 39.57% | 40.79% |
| Research & Development | 173.49B | 191.35B | 146.03B | 137.99B | 126.67B | 122.03B | 108.64B | 112.28B | 98.21B | 76.99B | 73.62B | 70.95B | 60.16B | 56.85B | 44.83B | 34.43B | 27.16B |
| General & Administrative | 34.48B | 44.30B | 39.25B | 39.24B | 41.63B | 40.78B | 40.32B | 39.45B | 37.51B | 32.11B | 28.46B | 26.79B | 23.84B | 21.33B | 24.84B | 20.02B | 14.73B |
| Selling & Marketing | 99.93B | 120.77B | 129.88B | 106.01B | 70.64B | 51.40B | 44.10B | 42.81B | 40.07B | 37.05B | 34.22B | 28.70B | 33.32B | 33.00B | 25.86B | 27.97B | 33.49B |
| SG&A | 134.40B | 165.07B | 169.13B | 145.24B | 112.27B | 92.18B | 84.41B | 82.26B | 77.59B | 69.15B | 62.68B | 55.48B | 57.15B | 54.33B | 50.70B | 47.99B | 48.21B |
| Other Expenses | 142.31B | 144.12B | 131.70B | 107.11B | 93.08B | 1.61B | 226.10M | 648.08M | -3.97B | -1.74B | -657.33M | 2.16B | 539.00M | -2.60B | -7.08B | -7.01B | -5.96B |
| Operating Expenses | 450.20B | 500.54B | 446.86B | 390.34B | 332.02B | 295.63B | 276.51B | 273.63B | 247.32B | 213.53B | 196.09B | 179.22B | 170.78B | 169.06B | 150.36B | 136.31B | 121.96B |
| Cost & Expenses | 1,592.39B | 1,630.05B | 1,464.09B | 1,453.83B | 1,329.42B | 1,284.64B | 1,197.62B | 1,119.45B | 956.13B | 878.36B | 809.36B | 737.42B | 679.84B | 645.39B | 523.82B | 448.17B | 383.85B |
| Interest Income | 3.19B | 3.47B | 1.27B | 1.19B | 1.97B | 1.86B | 1.49B | 928.00M | 778.00M | 587.00M | 521.00M | 836.41M | 3.09B | 2.22B | 1.10B | 919.07M | 646.86M |
| Interest Expense | 28.48B | 18.39B | 12.50B | 10.35B | 9.61B | 7.61B | 6.30B | 5.39B | 5.02B | 4.64B | 1.79B | 2.13B | 3.40B | 5.37B | 9.56B | 6.76B | 3.58B |
| Depreciation & Amortization | 75.90B | 64.82B | 55.49B | 48.33B | 46.52B | 40.01B | 36.60B | 30.95B | 28.43B | 23.52B | 18.42B | 15.66B | 13.04B | 19.23B | 16.74B | 10.42B | 10.47B |
| EBITDA | 109.81B | 187.04B | 159.01B | 168.79B | 57.80B | 97.77B | 115.06B | 115.85B | 120.08B | 120.27B | 97.23B | 90.41B | 102.49B | 159.30B | 130.96B | 76.38B | 64.41B |
| EBITDA Ratio | 6.75% | 10.13% | 15.11% | 5.63% | 5.83% | 6.73% | 8.88% | 9.73% | 15.72% | 15.00% | 10.69% | 11.14% | 13.39% | 20.35% | 21.17% | 10.14% | 14.56% |
| Operating Income | 34.44B | 81.26B | 176.41B | 35.90B | 40.25B | 50.15B | 90.30B | 78.45B | 91.68B | 96.97B | 78.81B | 74.36B | 88.34B | 145.63B | 119.39B | 67.93B | 58.45B |
| Operating Income Ratio | 2.12% | 4.75% | 11.47% | 2.39% | 2.94% | 3.76% | 7.01% | 6.55% | 8.75% | 9.94% | 8.87% | 9.16% | 11.50% | 18.41% | 18.56% | 13.16% | 13.21% |
| Total Other Income/Expenses | -61.57B | 4.46B | -3.85B | 54.22B | -42.84B | -5.41B | -18.15B | 1.06B | 37.21B | 19.69B | 12.22B | -1.25B | -2.28B | -10.93B | -14.73B | -8.73B | 1.67B |
| Income Before Tax | -27.13B | 85.73B | 172.56B | 104.47B | -6.14B | 50.15B | 72.15B | 79.51B | 128.89B | 116.65B | 91.03B | 73.11B | 86.06B | 134.70B | 104.65B | 59.20B | 60.12B |
| Income Before Tax Ratio | -1.67% | 5.01% | 11.22% | 6.95% | -0.45% | 3.76% | 5.60% | 6.64% | 12.30% | 11.96% | 10.25% | 9.01% | 11.21% | 17.03% | 16.27% | 11.47% | 13.59% |
| Income Tax Expense | -7.33B | 16.31B | 35.61B | 15.37B | 5.15B | 15.90B | 15.44B | 14.36B | 33.20B | 29.86B | 19.00B | 17.50B | 28.46B | 30.01B | 24.13B | 10.33B | 15.76B |
| Net Income | -26.63B | 65.45B | 123.21B | 81.05B | -11.29B | 34.43B | 53.25B | 62.97B | 94.97B | 83.94B | 70.07B | 53.64B | 55.37B | 104.69B | 80.52B | 48.87B | 44.36B |
| Net Income Ratio | -1.64% | 3.82% | 8.01% | 5.39% | -0.82% | 2.58% | 4.13% | 5.26% | 9.06% | 8.61% | 7.89% | 6.61% | 7.21% | 13.23% | 12.52% | 9.47% | 10.03% |
| EPS | -2.33K | 5.73K | 10.80K | 7.04K | -988.98 | 3.02K | 4.67K | 5.45K | 8.21K | 7.26K | 6.14K | 4.95K | 5.17K | 10.58K | 8.29K | 5.08K | 4.63K |
| EPS Diluted | -2.33K | 5.73K | 10.80K | 7.04K | -988.98 | 3.02K | 4.67K | 5.45K | 8.21K | 7.26K | 6.14K | 4.95K | 5.17K | 10.46K | 8.28K | 5.08K | 4.63K |
| Weighted Avg Shares Out | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.55M | 11.56M | 11.56M | 11.41M | 10.84M | 10.71M | 9.89M | 9.72M | 9.63M | 9.58M |
| Weighted Avg Shares Out (Dil) | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.41M | 11.55M | 11.56M | 11.56M | 11.41M | 10.84M | 10.71M | 10.01M | 9.73M | 9.63M | 9.58M |
Source: https://incomestatements.info
Category: Stock Reports